Tamas Koncz, MD, MSc, Ph.D., is Chief Medical Officer (CMO) for the Inflammation and Immunology (I&I) Business at Pfizer. As CMO, Tamas leads the medical affairs organization, medical professionals across the world who are responsible for ensuring the safe and effective use of Pfizer I&I medicines, as well as continuous data generation and dissemination to advance the understanding of the medicines' benefit: risk profiles. Medical affair colleagues are also involved in projects supporting research and early and late phase development, regulatory affairs, reimbursement and lifecycle management of the medicines. Throughout his career, Tamas has held various roles as a VP Global TA Lead, Global and European Medical Director, UK country medical adviser, health economist working with a broad portfolio and medical devices. Tamas holds an MD from the University of Debrecen, Hungary. Additionally, he completed an MSc in Economics at the Corvinus University, Budapest, an MSc in Health Economics at the University of York, UK and an MSc in Pharmaceutical Medicine at the University of Surrey, UK. Tamas also holds a Ph.D. from Semmelweis University, Hungary.